Development of a first-in-class drug against ejaculatory disorders

开发治疗射精障碍的一流药物

• 批准号: 342886
• 负责人: Guertin Pierre
• 金额: $ 17.82万
• 依托单位: CHU de Qubec
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2016
• 资助国家: 加拿大
• 起止时间: 2016-03-01 至 2018-03-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=342886&lang=en
• 关键词: Adrenergic; Anejaculation; Cns Drug Development; Delayed Ejaculation; Imidazolinergic; Quantitative Behavioral Assays; Reproductive Problems; Serotonergic; Sexual Dysfunctions; Spinal Cord Injury

In 1925, Sigmund Freud was among the first scientists to officially say that, as breathing and feeding, sex is also undoubtedly a life-sustaining activity. Today, almost every one of us would spontaneously agree that sex plays indeed a key role in life es

1925年，西格蒙德·弗洛伊德（Sigmund Freud）是第一批正式表示性与呼吸和喂养一样无疑也是维持生命的活动的科学家之一。今天，几乎我们每个人都会自然而然地同意，性在生活中确实扮演着一个关键角色。